Labshake search
Citations for Stemcell Technologies :
751 - 800 of 2070 citations for Human Endothelin 2 EDN2 CLIA Kit since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2021Quote: ... we respectively used mouse- and human-specific T cell negative isolation MACS (STEMCELL Technologies, Canada). We plated 0.5–1 × 106 T cells per well in 96-well V-bottom tissue culture plates ...
-
bioRxiv - Bioengineering 2020Quote: Human T cells were obtained by purchasing whole blood units from STEMCELL technologies (Vancouver, Canada). STEMCELL reported that these products are distributed using Institutional Review Board (IRB)-approved consent forms and protocols ...
-
bioRxiv - Bioengineering 2020Quote: ... CD8+ T cells were isolated using RosetteSep Human CD8+ T Cell Enrichment Cocktail (StemCell Technologies) following manufacturer’s protocol ...
-
bioRxiv - Bioengineering 2021Quote: ... Naïve primary human T cells (CD3+/CD4+/CD45RA+) were also sourced from STEMCELL Technologies (#70029) and cultured in RPMI with 10% FBS and IL-2 as described above ...
-
bioRxiv - Immunology 2022Quote: ... and human B-cell activating factor (BAFF) in 80 mL StemCell medium A (StemCell Technologies) containing 1 μg/mL of cyclosporine A (Millipore-Sigma) ...
-
bioRxiv - Developmental Biology 2022Quote: ... gradient centrifugation using the RosetteSep Human NK Cell Enrichment Cocktail (STEMCELL Technologies, Vancouver, BC, Canada).
-
bioRxiv - Cell Biology 2021Quote: Human cord blood CD34+ hematopoietic stem and progenitor cells (HSPCs) were purchased (StemCell Technologies #78003) or acquired through the Binns Program for Cord Blood Research at Stanford University under informed consent ...
-
bioRxiv - Cancer Biology 2021Quote: Human Peripheral Blood Pan-T Cells was purchased from Stem Cell Technologies (Vancouver, BC, Canada) and Panc-1 cells were obtained from the Kansas University Medical Center ...
-
bioRxiv - Bioengineering 2019Quote: ... before adding 250μL/well of either human IntestiCult™ Organoid Growth Medium (STEMCELL Technology, #06010) or human organoid basal culture media consisting of conditioned media produced using stably transfected L cells (Wnt 50% ...
-
bioRxiv - Cancer Biology 2019Quote: ... according to the manual for Human Colony-forming Unit (CFU) Assays Using MethoCult (StemCell Technologies).
-
bioRxiv - Genomics 2021Quote: ... hematopoietic colony-forming unit were automated counted and analyzed by STEMvision™ Human (STEMCELL Technologies). Differentiation frequency was calculated for each sorted population by number of resulting colonies/numbers of starting cells seeded.
-
bioRxiv - Physiology 2021Quote: ... The colonoids were maintained in Human IntestiCult Organoid Growth Medium (STEMCELL Technologies, Inc, Vancouver, BC). The human colonoids were transfected with the plasmids for fluorescent protein tagged human ALS-causing mutation SOD1G93A-GFP ...
-
bioRxiv - Immunology 2021Quote: ... from healthy buffy coat donors and incubated overnight with human recombinant Interleukin 15 (STEMCELL Technologies). NK cells were incubated with immune complexes ...
-
bioRxiv - Cancer Biology 2021Quote: ... Cells were activated with 1X ImmunoCult Human CD3/CD28 T Cell Activator (#10971, Stemcell Technologies) and cultured for 4 days ...
-
bioRxiv - Immunology 2021Quote: Human peripheral blood from de-identified healthy donors was purchased from STEMCELL Technologies (Vancouver, Canada), which collects and distributes de-identified human blood products with consent forms ...
-
bioRxiv - Immunology 2022Quote: ... and activated using ImmunoCult™ Human CD3/CD28/CD2 T Cell Activator (StemCell Technology, #10970) with or without 2µM of NU74411 for 48 hours.
-
bioRxiv - Developmental Biology 2022Quote: ... 5iLA naive human PSCs were dissociated into single cells by incubation with Accumax (Stemcell technologies) for 3 min at 37 °C ...
-
bioRxiv - Microbiology 2022Quote: ... plated in matrigel and cultured with 500 μl/well human IntestiCult™ OGM (Stemcell Technologies). Medium was changed every 2-3 days and organoids were passaged once a week ...
-
bioRxiv - Immunology 2022Quote: ... with an additional granulocyte depletion step using the RosetteSep Human Granulocyte Depletion Cocktail (STEMCELL Technologies) as directed by the manufacturer ...
-
bioRxiv - Immunology 2023Quote: ... Human blood-derived mast cells were plated between 40,000–50,000/well in StemSpan (StemCell Technologies) serum-free medium supplemented with Stem Cell Factor (Peprotech ...
-
bioRxiv - Genetics 2023Quote: Human induced pluripotent stem cells (iPSCs) were maintained in mTeSR+ medium (Stem Cell Technologies #05825) on tissue culture-treated plates coated with Matrigel (Corning #354277) ...
-
bioRxiv - Immunology 2023Quote: ... we used mouse-specific and human-specific T cell negative isolation MACS (STEMCELL Technologies, Canada). We plated 0.5–1 × 106 T cells per well in 96-well V-bottom tissue culture plates ...
-
bioRxiv - Immunology 2023Quote: ... CD14+ Mo were FACS sorted from frozen human bone marrow mononuclear cells (Stem Cell Technologies) on a BD FACS Melody Cell Sorted (BD Biosciences ...
-
bioRxiv - Pharmacology and Toxicology 2023Quote: ... PBMCs were activated with ImmunoCult human CD3/CD28 T cell activator (STEMCELL Technologies; Cat. # 10971) and 50 U/mL IL-2 (BD-Pharmingen ...
-
Human CCR6+ Th cells show both an extended stable gradient of Th17 activity and imprinted plasticitybioRxiv - Immunology 2023Quote: ... Stimulation was done using ImmunoCult human CD3/CD28/CD2 T Cell Activator (Stem Cell Technologies) in non-polarizing conditions using anti-IL-4 (5 μg/ml) ...
-
bioRxiv - Genomics 2023Quote: ... WTC11 human iPSCs (RRID:CVCL_Y803) were cultured in mTeSR plus medium (Stemcell technologies, Catalog # 100-0276) and passaged using ReLeSR (Stemcell technologies ...
-
bioRxiv - Biophysics 2023Quote: ... medium was replaced by 250µL of Intesticult ODM human basal medium (StemCell technologies, 100-0214), allowing generation of intestinal organoid cultures with physiological representations of the stem cell and differentiated population ...
-
bioRxiv - Developmental Biology 2023Quote: Shef6 human ESCs were cultured on Matrigel-coated plates in mTESR medium (05825, STEMCELL Technologies) at 37°C ...
-
bioRxiv - Neuroscience 2023Quote: ... Human DS and control iPSCs were cultured and maintained in mTeSR1 medium (Stem Cell Technologies) in tissue culture dishes coated with hESC-qualified Matrigel (Corning) ...
-
bioRxiv - Cell Biology 2023Quote: ... H1 human embryonic stem-cell (H1-hESC) line was cultured in mTeSR1 medium (STEMCELL Technologies) under 5% CO2 at 37℃ and was sub-cultured when reaching 80% confluence ...
-
bioRxiv - Bioengineering 2023Quote: ... Human induced pluripotent stem cell (hPSC) line PGP1 was cultured with mTeSR1 (STEMCELL Technologies, #85850) in tissue culture 6-well plates coated with reduced growth factor Geltrex (Gibco ...
-
bioRxiv - Microbiology 2023Quote: A three-stage protocol was used to differentiate human bone marrow CD34+ cells (STEMCELL Technologies) down the erythroid lineage as previously described.37 Briefly ...
-
bioRxiv - Immunology 2023Quote: ... PBMCs from human blood samples were isolated on a density gradient medium (Lymphoprep, STEMCELL Technologies). Cells were incubated 4°C for 10 min with anti-mouse or anti-human CD16/CD32 (BD Pharmingen ...
-
bioRxiv - Immunology 2024Quote: ... and stimulated with 25μL/mL ImmunoCult Human αCD2/αCD3/αCD28 T cell Activator (STEMCELL Technologies) or 10μL/mL T-cell TransAct αCD3/αCD28 (Miltenyi Biotec) ...
-
bioRxiv - Molecular Biology 2024Quote: G-CSF Mobilized Human Peripheral Blood CD34+ Cells were purchased from StemCell Technologies (Catalog: 70060.1). Cells were thawed by resuspending in 10 mL of RPMI without FBS ...
-
bioRxiv - Cancer Biology 2023Quote: ... and 2 H3.1-K27M (GSC3, GSC4) cellular models were grown in NeurocultTM medium supplemented with heparin (2 μg/mL, Stemcell Technologies), EGF/FGF (20ng/mL ...
-
bioRxiv - Cancer Biology 2019Quote: ... 2 μg/mL Heparin (StemCell Technologies, Cat 07980), 1× antibiotic-antimicotic (Life Technologies Gibco ...
-
bioRxiv - Cancer Biology 2020Quote: ... heparin (2 μg/ml; Stem Cell Tech, #07980), and Antibiotic-Antimycotic solution (0.1% ...
-
bioRxiv - Genetics 2022Quote: ... 2 μM doxycycline and CloneR supplement (StemCell Technologies) to enhance the viability of single cells ...
-
bioRxiv - Neuroscience 2020Quote: ... and heparin (2 μg/mL, StemCell Technologies, #07980).
-
bioRxiv - Cancer Biology 2020Quote: ... 2 μg/mL Heparin (Stem Cell Technologies #07980) and L-glutamine (2mM ...
-
bioRxiv - Neuroscience 2021Quote: ... supplemented with 2% NeuroCult SM1 supplement (STEMCELL Technologies) and 1% penicillin/streptomycin (Gibco) ...
-
bioRxiv - Cell Biology 2021Quote: ... containing 2% NeuroCult SM1 supplement (StemCell Technologies, 05711), 1% L-glutamine (Corning ...
-
bioRxiv - Cancer Biology 2021Quote: ... and 2 μg/mL heparin (StemCell Technologies, #07980). All cultures were used within the first 20 passages of generation ...
-
bioRxiv - Immunology 2020Quote: ... with 2 mL Spleen Dissociation Medium (STEMCELL Technologies) and homogenized using the Miltenyi GentleMacs dissociator ...
-
bioRxiv - Cancer Biology 2020Quote: ... and 2 μg/mL heparin (StemCell Technologies, #07980); 500 μL of 25% BSA (Millipore-Sigma ...
-
bioRxiv - Cancer Biology 2020Quote: ... and 2 μg/mL heparin (Stem Cell Technologies), as previously described (Tominaga et al. ...
-
bioRxiv - Neuroscience 2022Quote: ... and 2 µM of XAV939 (STEMCELL Technologies, #72674) were added to induce cerebro-cortical differentiation ...
-
bioRxiv - Neuroscience 2022Quote: ... 2 mL of ReLeSR (StemCell Technologies, cat.no. 05872) solution was applied for 30 seconds at room temperature ...
-
bioRxiv - Neuroscience 2022Quote: ... and 2 μM of XAV939 (#72674, StemCell Technologies). The medium was changed daily until day 11 ...